Atopic dermatitis is a chronic skin condition for which a range of systemic treatments have recently been approved. A ‘treat to target’ strategy has been developed alongside an algorithm to guide the management of patients with atopic dermatitis.
In this session, Dr Andrew Pink and A/Prof Peter Foley review the strategy and algorithm in the evolving therapeutic landscape and identify areas for further refinement and development.
Key Areas Explored:
Current landscape of atopic dermatitis treatment
The benefit of introducing targets
Impactful drugs and treat-to-target principles